SCHEMBL2373465

SCHEMBL2373465

O=C(O)c1cc(-c2cccc(C(F)(F)F)c2)nc2ccccc12

nearest known ligand 0.69

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.69
LMNA P02545 1/20 0.69
SMN1; SMN2 Q16637 1/20 0.69
PDE10A Q9Y233 1/20 0.69
AKR1C3 P42330 1/20 0.67
AKR1C2 P52895 1/20 0.67
AKR1C1 Q04828 1/20 0.67
DHODH Q02127 7/20 0.66
CA12 O43570 3/20 0.62
CA1 P00915 3/20 0.62
CA2 P00918 3/20 0.62
CA9 Q16790 3/20 0.62
ALDH1A1 P00352 1/20 0.60
MAPT P10636 1/20 0.60
POLB P06746 1/20 0.59
MEN1 O00255 1/20 0.56
KMT2A Q03164 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2372402 0.90 CA12 (0.63) KDM4ELMNASMN1; SMN2PDE10AAKR1C3
SCHEMBL30690068 0.87 DHODH (0.63) KDM4ELMNASMN1; SMN2PDE10AAKR1C3
SCHEMBL116029 0.86 DHODH (0.74) KDM4ELMNASMN1; SMN2PDE10ADHODH
SCHEMBL4246561 0.85 DHODH (0.55) KDM4ELMNASMN1; SMN2PDE10AAKR1C3
SCHEMBL10760636 0.84 CA12 (0.55) KDM4ELMNASMN1; SMN2PDE10AAKR1C3
SCHEMBL8617534 0.83 CA12 (0.64) KDM4ELMNASMN1; SMN2PDE10AAKR1C3
Cinchophen SCHEMBL25519 0.83 KDM4E (1.00) KDM4ELMNASMN1; SMN2PDE10AAKR1C3
Cinchophen SCHEMBL7588217 0.83 KDM4E (1.00) KDM4ELMNASMN1; SMN2PDE10AAKR1C3
Cinchophen SCHEMBL29376617 0.83 KDM4E (1.00) KDM4ELMNASMN1; SMN2PDE10AAKR1C3
SCHEMBL10610235 0.82 CA12 (0.54) KDM4EAKR1C3AKR1C2AKR1C1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011119693-A1 TRPV4 ANTAGONISTS GLAXOSMITHKLINE LLC (US) 2011-09-29 WO disclosed
EP-0726254-B1 Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds MITSUI TOATSU CHEMICALS (JP) 1998-05-06 EP disclosed
US-5627193-A MEDICAL DIAGNOSIS, CARDIOVASCULAR DIAORDERS AND PROTECTION OF ORGANS FOR TRANSPLANTATION MITSUI TOATSU CHEMICALS, INC. (JP) 1997-05-06 US disclosed
EP-0726254-A1 Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds MITSUI TOATSU CHEMICALS, Inc. (JP) 1996-08-14 EP disclosed
US-4711890-A TREATMENT OF ANXIETY STATES OR OF PULMONARY, RENAL, CIRCULATORY OF CARDIOVASCULAR DISORDERS RHONE-POULENC SANTE (FR) 1987-12-08 US disclosed
US-4684652-A TREATING ANXIETY OR CARDIOVASCULAR DISORDERS RHONE-POULENC SANTE (FR) 1987-08-04 US disclosed
US-4402961-A Derivatives of 1-(2-,3- or 4-quinolyl)-2- or -3-(2- or 3-piperidyl or -pyrrolidinyl) ethanone or propanone, and their utilization as antiarrhythmics, anticonvulsivants and for the treatment of anxiety PHARMINDUSTRIE (FR) 1983-09-06 US disclosed